A postmarket safety review of varenicline (marketed as Chantix) and 
bupropion (marketed as Zyban and generics), two products used for 
smoking cessation, has identified cases where suicidal ideation and 
behaviors followed the initiation of treatment with these drugs.

<http://digg.com/u14kSx#TheSmokingCessationAidsVareniclineMarketedasChantixandBupropionMarketedasZybanandGenerics:SuicidalIdeationandBehavior>http://digg.com/u14kSx#TheSmokingCessationAidsVareniclineMarketedasChantixandBupropionMarketedasZybanandGenerics:SuicidalIdeationandBehavior 

or
<http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm110235.htm#TheSmokingCessationAidsVareniclineMarketedasChantixandBupropionMarketedasZybanandGenerics:SuicidalIdeationandBehavior>http<http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm110235.htm#TheSmokingCessationAidsVareniclineMarketedasChantixandBupropionMarketedasZybanandGenerics:SuicidalIdeationandBehavior>://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm110235.htm#TheSmokingCessationAidsVareniclineMarketedasChantixandBupropionMarketedasZybanandGenerics:SuicidalIdeationandBehavior 




www.peoplewho.org